GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kohjin Bio Co Ltd (TSE:177A) » Definitions » Other Current Assets

Kohjin Bio Co (TSE:177A) Other Current Assets : 円0 Mil (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Kohjin Bio Co Other Current Assets?

Kohjin Bio Co's other current assets for the quarter that ended in Jun. 2024 was 円0 Mil.

Kohjin Bio Co's quarterly other current assets declined from Dec. 2023 (円288 Mil) to Mar. 2024 (円252 Mil) and declined from Mar. 2024 (円252 Mil) to Jun. 2024 (円0Mil).

Kohjin Bio Co's annual other current assets declined from Mar. 2022 (円385 Mil) to Mar. 2023 (円238 Mil) increased from Mar. 2023 (円238 Mil) to Mar. 2024 (円252 Mil).


Kohjin Bio Co Other Current Assets Historical Data

The historical data trend for Kohjin Bio Co's Other Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kohjin Bio Co Other Current Assets Chart

Kohjin Bio Co Annual Data
Trend Mar22 Mar23 Mar24
Other Current Assets
385.47 238.35 252.45

Kohjin Bio Co Quarterly Data
Mar22 Mar23 Dec23 Mar24 Jun24 Sep24
Other Current Assets Get a 7-Day Free Trial 238.35 287.57 252.45 - 232.99

Kohjin Bio Co Other Current Assets Calculation

Technically, the other current assets line may include any asset that will be used up within the next 12 months. However, other current assets never include assets that are listed elsewhere in the current assets section of the balance sheet. For this reason, other current assets are almost never:


Cash
Trade Receivables
Inventory

The assets grouped under other current assets are most commonly:


Prepaid Expenses
Tax Assets
Non-Trade Receivables
Other (too numerous to list)

Some companies can and do choose to report each of these items separately.

Other current assets may be made up largely of Prepaid Expenses - unless these are listed on a separate line of the balance sheet.

Prepaid expenses are exactly what they sound like. If a company pays a $30 million insurance premium on the last day of June that will provide coverage for the entire month of July, the company will record a $30 million prepaid expense to account for the insurance expense it will show in July that it already paid for in June.

Tax assets can be quite complex. It is not common for companies to have both tax assets and tax liabilities. It is important that investors take note of both items when considering future taxes.

Non-Trade receivables are rarely a large item. They include money owed to the company by non-customers. Non-trade receivables can be caused by related party transactions, the sale of a business unit, etc. The notes to the company's financial statements will often provide much more detail on this item if it is truly important.

There are a variety of other current assets like non-trade receivables which are simply too numerous to list. If a company is following correct reporting procedures, it should not lump items that are different from one another and yet individually important to the company together under the line Other Current Assets.

At most companies, other current assets are a small and unimportant part of the total balance sheet.


Kohjin Bio Co Other Current Assets Related Terms

Thank you for viewing the detailed overview of Kohjin Bio Co's Other Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Kohjin Bio Co Business Description

Traded in Other Exchanges
N/A
Address
5-1-3 Chiyoda, Sakado, Saitama, JPN, 350-0214
Kohjin Bio Co Ltd is engaged in development, manufacture and sale of culture media (growing environments used for culturing microorganisms and cells) and contract manufacturing of processed cell products. It has manufacturing and sales of animal blood, sera, tissue culture media, media for microbiology testing, in vitro diagnostic agents, and cosmetics.

Kohjin Bio Co Headlines

No Headlines